Radius Health

+$0.22 (+3.67%) As of 6:37 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Radius Health and other ETFs, options, and stocks.

About RDUS

Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis.

CEO
George Kelly Martin
Employees
293
Headquarters
Boston, Massachusetts
Founded
2003

RDUS Key Statistics

Market cap
295.89M
Price-Earnings ratio
—
Dividend yield
—
Average volume
989.60K
High today
$6.24
Low today
$6.02
Open price
$6.03
Volume
222.37K
52 Week high
$23.00
52 Week low
$4.97

RDUS News

Simply Wall StMay 21

Breakeven On The Horizon For Radius Health, Inc.

With the business potentially at an important milestone, we thought we'd take a closer look at Radius Health, Inc.'s ( ) future prospects. Radius Health, Inc.,
BenzingaMay 20

Menarini, Radius Health's Elacestrant Prolongs Progression Free Survival In Breast Cancer - Yahoo Finance

The Menarini Group and Radius Health Inc's (NASDAQ: RDUS) data from the phase 3 EMERALD trial evaluating elacestrant for ER+/HER2- advanced or metastatic breast

RDUS Earnings

-$0.42
-$0.23
-$0.04
$0.15
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure